May
| May 3 | |
| Opportunities and challenges in the development of effective treatments for rare tumors and genetic tumor predisposition syndromes | Brigitte C. Widemann, M.D. Head, Pharmacology and Experimental Therapeutics Section Pediatric Oncology Branch Center for Cancer Research, NCI |
| May 10 | |
| No Lecture | |
| May 17 | |
| Maintaining Genome Stability during Replication and Class Switching | Andre Nussenzweig, Ph.D. Chief, Laboratory of Genome Integrity Center for Cancer Research, NCI |
| May 24 | |
| No Lecture – Memorial Day Weekend | |
| May 31 | |
| No Lecture - ASCO | |
June
| June 7 | |
| Oncology Nursing Lecture | |
| June 14 | |
| Impact of HLA Diversity on HIV Control: The Art of Multitasking | Mary N. Carrington, Ph.D. Head, HLA Typing Section Laboratory of Experimental Immunology NCI-Frederick |
| June 21 | |
| Aberrant Ras and Rho Signaling: Drugging the Undruggable | Channing J. Der, Ph.D. Kenan Distinguished Professor UNC Lineberger Comprehensive Cancer Center School of Medicine |
General information about Grand Rounds
Lipsett Amphitheater, Building 10, Fridays, 12:00–1:00 p.m.
Telephone contact: 301-496-4345
Educational Objectives
After attending this activity, the participant should be able to describe the novel aspects of the basic and/or clinical research in cancer prevention, diagnosis, or treatment presented by the speaker. Participants should also be able to discuss the potential applications of the research and/or therapeutic approaches presented by the speaker and the impact that this is likely to have in advancing the field of oncology research and practice.
If you are an individual with a disability who needs any assistance or assistive devices to participate in this event, please call Romi Sawhney at 301-496-4345 three days prior to the seminar so that we can discuss your needs.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
Back to Top
